Acquired resistance of Pseudomonas aeruginosa to beta-lactam antibiotics, e.g. ticarcillin, has the following characters: The incidence of ticarcillin-resistant strains is about 21% but it varies with hospitals from 10.9 to 35.1%. Resistance is predominantly due to beta-lactamases, which are produced by two-thirds of the strains (64.4% in 1982, 67.9% in 1983). The presence of beta-lactamase positive strains is dependent upon the type of patient, the hospital unit (e.g. urology or burns) and the nature of the specimen collected. Most beta-lactamase positive strains spontaneously produce one single penicillinase of the CARB (53.8%), OXA (30.5%) or TEM (8.7%) type. New types of beta-lactamases may develop and hydrolyse beta-lactam antibiotics such as ticarcillin, azlocillin, cefoperazone or cefsulodin. With beta-lactam antibiotics (cefotaxime, moxalactam, ceftazidime) that resist hydrolysis, bacterial resistance is due to production of a constitutive beta-lactamase of the cephalosporinase type. This enzyme has recently appeared and its incidence is low (6.8%). Associated beta-lactamases (e.g. penicillinase plus cephalosporinase) are exceptional.

Download full-text PDF

Source

Publication Analysis

Top Keywords

beta-lactam antibiotics
12
antibiotics ticarcillin
8
beta-lactamase positive
8
positive strains
8
[distribution constituent
4
beta-lactamases
4
constituent beta-lactamases
4
beta-lactamases pseudomonas
4
pseudomonas aeruginosa]
4
aeruginosa] acquired
4

Similar Publications

is an opportunistic human pathogen that acquires nutrient metals from the vertebrate host amid infection. During zinc (Zn) scarcity, upregulates the expression of the predicted Zn metallochaperone, . Loss of compromises fitness during Zn deficiency, highlighting its role in this condition.

View Article and Find Full Text PDF

Background: Antimicrobial resistance (AMR) is caused by the use and misuse of antibiotics. AMR is a global health concern, to which penicillin allergy (penA) labels appear to contribute. Patients who have penA labels are treated with non-penicillin antibiotics and receive more antibiotics when compared with patients without penA.

View Article and Find Full Text PDF

Background: Guidelines suggest treating fully penicillin-susceptible Enterococcus faecalis strains causing infective endocarditis with amoxicillin combined with gentamicin or ceftriaxone, but clinical evidence to support this practice is limited and monotherapy cohorts were excluded from studies. We describe antibiotic treatment, complications, and outcomes in patients with Enterococcus faecalis infective endocarditis, specifically comparing monotherapy versus combination therapy.

Methods: Retrospective analysis of prospectively collected cohort of patients with definite or possible infective endocarditis from 2 English centres between 2006 and 2021.

View Article and Find Full Text PDF

Objective: To assess the efficacy and safety of cefiderocol (CFDC) in the treatment of Gram-negative bacteria (GNB) infections.

Methods: Relevant studies were collected from PubMed, Web of Science, Cochrane, and Embase databases, from inception to 15 October 2023. The search formula was as follow: "cefiderocol", "S-649266", "Gram-Negative Bacteria", "Gram Negative Bacteria", "Klebsiella pneumoniae", "Hyalococcus pneumoniae", and "Bacterium pneumoniae proposal".

View Article and Find Full Text PDF

Improving cefazolin administration for surgical prophylaxis in reported penicillin allergy: A retrospective study of a health system intervention.

J Allergy Clin Immunol Glob

February 2025

Section of Rheumatology, Allergy, and Immunology, Department of Internal Medicine, Yale School of Medicine, New Haven, Conn.

Background: Cefazolin is the most common first-line antibiotic to prevent surgical-site infections. Patients with penicillin allergy labels often receive alternative antibiotics, which is associated with increased rates of surgical-site infections, multi-drug-resistant infections, and cost.

Objective: We sought to determine whether a hospital-wide guideline recommending first-line surgical prophylaxis in patients with penicillin allergy labels can increase the use of cefazolin without compromising safety.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!